Particles that shut off cancer genes could also allow researchers to screen potential drug targets more rapidly.
CAMBRIDGE, Mass.–(ENEWSPF)–August 16, 2012. By sequencing cancer-cell genomes, scientists have discovered vast numbers of genes that are mutated, deleted or copied in cancer cells. This treasure trove is a boon for researchers seeking new drug targets, but it is nearly impossible to test them all in a timely fashion.
To help speed up the process, MIT researchers have…
